Evidence map›Paper›PMID 26460824›Full record

ArticleOncotarget2015

Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes.

Laurence Froidevaux-Klipfel, Benjamin Targa, Isabelle Cantaloube, Hayat Ahmed-Zaïd, Christian Poüs, Anita Baillet

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Spatial control of membrane traffic in neuronal dendrites.Molecular and cellular neurosciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laurence Froidevaux-KlipfelINSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Benjamin TargaINSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Isabelle CantaloubeINSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Hayat Ahmed-ZaïdINSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Christian PoüsINSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Anita BailletINSERM, UMR-S-1193, Université Paris-Saclay, Châtenay-Malabry, France.
Université Paris-Saclay · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms of cancer cell adaptation to the anti-microtubule agents of the taxane family are multifaceted and still poorly understood. Here, in a model of breast cancer cells which display amplified microtubule dynamics to resist Taxol®, we provide evidence that septin filaments containing high levels of SEPT9_i1 bind to microtubules in a way that requires tubulin long chain polyglutamylation. Reciprocally, septin filaments provide a scaffold for elongating and trimming polyglutamylation enzymes to finely tune the glutamate side-chain length on microtubules to an optimal level. We also demonstrate that tubulin retyrosination and/or a high level of tyrosinated tubulin is crucial to allow the interplay between septins and polyglutamylation on microtubules and that together, these modifications result in an enhanced CLIP-170 and MCAK recruitment to microtubules. Finally, the inhibition of tubulin retyrosination, septins, tubulin long chain polyglutamylation or of both CLIP-170 and MCAK allows the restoration of cell sensitivity to taxanes, providing evidence for a new integrated mechanism of resistance.

Indexed as

Breast NeoplasmsCell Line, TumorDrug Resistance, NeoplasmHumansMicrotubulesPaclitaxelPolyglutamic AcidSeptinsTubulinPaclitaxelPolyglutamic AcidSeptinsTubulinmicrotubule polyglutamylationseptinTaxol® resistancetyrosinated tubulin

Identifiers

PMID26460824
PMCPMC4742162
OpenAlexW2215895566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.